V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019567 | 270014316 | 1.72 | 85.2 | Curative (C) | 2017-12-27 | 2017-12-27 | Cisplatin + Radiotherapy + CISPLATIN | 2 | N | 270015329 | CISPLATIN + RT |
| 270019568 | 270019184 | 1.86 | 66 | Adjuvant (A) | 2017-01-06 | 2017-02-04 | HD EuroNet-PHL-C1 OEPA | null | null | 270015404 | OEPA |
| 270019569 | 270009266 | 1.67 | 50 | null | 2016-11-14 | 2016-11-20 | BMT BEAM | 2 | N | 270015410 | BEAM |
| 270019570 | 270009279 | 1.71 | 75.7 | null | 2016-04-15 | 2016-04-23 | HD EuroNet-PHL-C1 OEPA | N | N | 270015462 | OEPA |
| 270019571 | 270016878 | 1.58 | 78.6 | Palliative (P) | 2019-06-23 | 2019-06-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270015465 | CETUXIMAB + IRINOTECAN + MDG |
| 270019572 | 270014343 | 1.87 | 94 | Not known (9) | 2018-06-30 | 2018-07-03 | Rituximab | 2 | N | 270015489 | RITUXIMAB |
| 270019573 | 270016885 | 1.7 | 95.7 | Curative (C) | 2016-05-07 | 2016-05-07 | LEAM | N | N | 270015522 | LEAM |
| 270019574 | 270009318 | 0 | 103.8 | Curative (C) | 2018-01-08 | 2018-01-18 | ESHAP | N | N | 270015528 | ESHAP |
| 270019575 | 270009338 | 1.77 | 36.4 | Adjuvant (A) | 2018-03-09 | 2018-03-10 | HD EuroNet-PHL-C1 OEPA | N | N | 270015562 | OEPA |
| 270019576 | 270014364 | 0 | null | Curative (C) | 2015-01-20 | 2015-01-23 | ESHAP | 2 | N | 270015578 | ESHAP |
| 270019577 | 270014365 | 1.66 | 96.2 | Curative (C) | 2016-03-08 | 2016-03-27 | CETUXIMAB + IRINOTECAN + MDG | N | null | 270015585 | CETUXIMAB + IRINOTECAN + MDG |
| 270019578 | 270016900 | 1.66 | 74.3 | Curative (C) | 2019-02-17 | 2019-02-21 | BEAM | N | N | 270015617 | BEAM |
| 270019579 | 270009403 | null | 71.4 | Neo-adjuvant (N) | 2016-02-18 | 2016-02-18 | Cetuximab + FOLFIRI cycle1 | 02 | null | 270015795 | CETUXIMAB + IRINOTECAN + MDG |
| 270019580 | 270009412 | null | 58.9 | Curative (C) | null | 2018-06-05 | ESHAP | 2 | N | 270015820 | ESHAP |
| 270019581 | 270019210 | 1.81 | 66 | null | 2018-02-17 | 2018-02-27 | Capecitabine (14 day) + Irinotecan | 02 | null | 270015884 | CAPECITABINE + IRINOTECAN |
| 270019582 | 270019213 | null | null | Palliative (P) | 2017-02-20 | 2017-03-27 | Trifluridine + Tipiracil | N | Y | 270015892 | TRIFLURIDINE + TIPIRACIL |
| 270019583 | 270014415 | 1.74 | 58 | Palliative (P) | 2018-10-14 | 2018-10-14 | Capecitabine (14 day) + Irinotecan | N | N | 270015908 | CAPECITABINE + IRINOTECAN |
| 270019585 | 270009458 | 1.6 | 68.4 | Curative (C) | 2016-08-31 | 2016-10-04 | CHLVPP | 2 | null | 270015948 | CHLVPP |
| 270019586 | 270009469 | 1.6 | 69 | Adjuvant (A) | 2016-05-17 | 2016-05-17 | CHOP R | 02 | N | 270015983 | CHOP R |
| 270019587 | 270009482 | 1.74 | 90 | Palliative (P) | 2016-08-07 | 2016-10-17 | Cetuximab + Radiotherapy Maint | N | N | 270016013 | CETUXIMAB + RT |
| 270019588 | 270009485 | 1.52 | 59 | Curative (C) | 2014-06-18 | 2015-02-18 | DHAP | N | N | 270016019 | DHAP |
| 270019589 | 270014439 | 1.74 | 79.6 | Curative (C) | null | 2019-03-24 | Cetuximab + Radiotherapy Load | N | N | 270016033 | CETUXIMAB + RT |
| 270019590 | 270019221 | 1.43 | null | Neo-adjuvant (N) | 2017-01-29 | 2017-07-14 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270016074 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270019591 | 270009503 | 1.81 | 59.6 | Curative (C) | 2017-06-16 | 2017-06-21 | CHLVPP | N | N | 270016133 | CHLVPP |
| 270019592 | 270009538 | 1.68 | 98 | Curative (C) | 2019-12-21 | 2019-12-31 | CHOP R - 21 days | 2 | N | 270016250 | CHOP R |
| 270019593 | 270009556 | null | null | Curative (C) | null | 2015-09-09 | CHOP R - 21 days | 02 | N | 270016297 | CHOP R |
| 270019594 | 270018410 | 1.75 | 65 | Palliative (P) | 2018-01-09 | 2019-04-25 | CHLVPP | 02 | Y | 270016323 | CHLVPP |
| 270019595 | 270009581 | null | 98 | Palliative (P) | 2018-05-22 | 2018-11-08 | Fluorouracil + Folinic Acid Weekly | N | N | 270016371 | FLUOROURACIL |
| 270019596 | 270019940 | 1.5 | 101.7 | Palliative (P) | 2020-05-02 | 2020-05-03 | Trifluridine + Tipiracil | 02 | N | 270016398 | TRIFLURIDINE + TIPIRACIL |
| 270019597 | 270009594 | 1.76 | 55.2 | Curative (C) | null | 2015-01-29 | CHLORAMBUCIL + DOXORUBICIN + ETOPOSIDE + Procarbazine + VINBLASTINE + VINCRISTINE | N | N | 270016405 | NOT MATCHED |
| 270019598 | 270016985 | 1.76 | 87.5 | Palliative (P) | 2016-03-08 | 2016-03-13 | Capecitabine (21 day) + Irinotecan | 02 | N | 270016426 | CAPECITABINE + IRINOTECAN |
| 270019599 | 270009610 | 1.69 | 60.6 | Palliative (P) | 2018-03-29 | 2018-04-11 | CISPLATIN + FLUOROURACIL | 02 | N | 270016434 | CISPLATIN + FLUOROURACIL |
| 270019600 | 270014498 | 1.7 | 89 | Curative (C) | 2015-11-07 | 2017-05-22 | HD EuroNet-PHL-C1 Relapsed ABVD | N | N | 270016438 | NOT MATCHED |
| 270019601 | 270016989 | null | 89.6 | Palliative (P) | 2018-10-01 | 2018-10-03 | CAPECITABINE + RT | N | N | 270016441 | CAPECITABINE + RT |
| 270019602 | 270009628 | 0 | null | Palliative (P) | 2015-03-16 | 2015-06-10 | Cetuximab + Radiotherapy Maint | N | N | 270016490 | CETUXIMAB + RT |
| 270019603 | 270014509 | 1.7 | null | Curative (C) | 2019-02-20 | 2019-03-13 | CAPECITABINE + RT | 02 | N | 270016502 | CAPECITABINE + RT |
| 270019604 | 270009650 | 1.61 | 84.8 | Radical (R) | 2018-06-28 | 2018-07-24 | CHOP R - 21 days | null | null | 270016559 | CHOP R |
| 270019605 | 270018430 | 1.71 | 94.3 | Disease modification (D) | 2018-05-28 | 2018-05-28 | DHAP | N | N | 270016596 | DHAP |
| 270019606 | 270009661 | 1.71 | 95.2 | Not known (9) | 2015-08-08 | 2015-09-03 | Fluouracil continuous infusion | N | N | 270016605 | FLUOROURACIL |
| 270019607 | 270009662 | null | 90 | Curative (C) | 2018-12-27 | 2019-01-11 | DHAP | N | N | 270016607 | DHAP |
| 270019608 | 270009670 | 1.82 | 80.4 | Curative (C) | 2016-12-09 | 2017-01-31 | Trifluridine + Tipiracil | 02 | N | 270016619 | TRIFLURIDINE + TIPIRACIL |
| 270019609 | 270009676 | 1.85 | 133.5 | Adjuvant (A) | 2017-07-05 | 2017-07-05 | GEM-P | N | null | 270016635 | GEMCITABINE + PACLITAXEL |
| 270019610 | 270009678 | 1.82 | 77.4 | Adjuvant (A) | 2019-03-21 | 2019-03-29 | Cyclophosphamide High Dose | N | N | 270016640 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019611 | 270009685 | null | 53.7 | null | null | 2017-02-02 | Panitumumab | null | null | 270016660 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019612 | 270009692 | 1.7 | 65 | Curative (C) | 2019-03-16 | 2019-03-16 | Cetuximab + Oxaliplatin + MdG Load | N | null | 270016676 | VINBLASTINE |
| 270019613 | 270009696 | 1.83 | 89 | Palliative (P) | 2015-06-28 | 2015-07-25 | Cisplatin 7 day | N | N | 270016682 | BEAM + ALEMTUZUMAB |
| 270019614 | 270014547 | null | 56 | Curative (C) | 2014-05-02 | 2014-05-03 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | 270016705 | ABVD R |
| 270019615 | 270009705 | null | 128 | Curative (C) | 2015-01-27 | 2015-10-19 | Vinblastine | N | N | 270016708 | VEPEMB |
| 270019616 | 270009718 | null | 69.8 | Adjuvant (A) | 2015-10-20 | 2015-11-22 | Panitumumab | N | N | 270016750 | VEPEMB |
| 270019617 | 270009722 | 1.65 | 53.4 | Disease modification (D) | 2017-06-27 | 2017-07-05 | BENDAMUSTINE | N | N | 270016757 | BENDAMUSTINE |